Inactief instrument

Andere talen Dermira, Inc.

Aandelen

US24983L1044

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

QBREXZA Receives Manufacturing and Marketing Approval in Japan Triggering $2.5 Million Payment to Journey Medical Corporation and $7.5 Million to Dermira Inc	11-02-22
Journey Medical Corp completed the acquisition of Qbrexza from Dermira, Inc.	30-04-21
Journey Medical Corp entered into a definitive agreement to acquire Qbrexza from Dermira, Inc. for $160 million.	31-03-21
Evommune, Inc. Enters into an Exclusive License Agreement with Dermira, Inc	07-01-21
Eli Lilly and Company and Dermira Present New Lebrikizumab Phase 2B Clinical Data Showing Patients with Atopic Dermatitis Had Clinically Meaningful Improvements in Itch, Sleep and Quality of Life	12-06-20
Dermira : Form 15-12B - Securities Registration Termination	02-03-20
Dermira : SEC Filing - S-8 POS	20-02-20
Dermira : SEC Filing - POS AM	20-02-20
Dermira, Inc. Announces Board Changes	20-02-20
Dermira : Lilly Completes Acquisition of Dermira	20-02-20
Dermira, Inc.(NasdaqGS:DERM) dropped from S&P Global BMI Index	20-02-20
Dermira, Inc.(NasdaqGS:DERM) dropped from S&P TMI Index	20-02-20
Eli Lilly and Company completed the acquisition of 74.8% stake in Dermira, Inc. from a group of sellers.	19-02-20
Dermira : Statement of Ownership	10-02-20
Dermira : Eli Lilly profit beat helps ease investor concerns over growth	30-01-20
Dermira : Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 - CFO	17-01-20
Eli Lilly and : Lilly Announces Agreement to Acquire Dermira	13-01-20
WeissLaw LLP Investigates Dermira, Inc.	10-01-20
USA: Les valeurs à suivre à Wall Street	10-01-20
DERMIRA, INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	10-01-20

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Dermira, Inc.

Aandelen

US24983L1044

Andere talen

Filters